Landmark Science, Inc. is a premier life science research organization providing real-world evidence and health outcomes research solutions. The company provides a comprehensive suite of services enabling the use of RWE in drug development. Landmark Science’s team of experts deliver RWE for clinical program strategy, health economics, commercial, market access, and regulators and payors to meet diverse needs efficiently. Specialties include complex study designs used to support regulatory submissions, therapeutic area expertise, and data landscaping.
Dr. Aggarwal holds a PhD in Epidemiology and an MS in Biostatistics, and brings over 15 years of experience spanning industry and academia. She brings a strategic, end‑to‑end perspective to evidence generation, aligning scientific rigor with the practical needs of development, medical, regulatory, safety, and market access teams. Known for her ability to translate complex real‑world data into clear, decision‑ready insights, Dr. Aggarwal specializes in selecting fit‑for‑purpose data sources and designing studies that support decision‑making across the product lifecycle.
At Landmark, Dr. Aggarwal leads a team of skilled epidemiologists and programmers, advancing evidence‑based insights and decision-making across the healthcare industry. Her team partners closely with clients to guide strategic initiatives that improve patient care, optimize treatment outcomes, and inform policy. Her commitment to leveraging data to drive meaningful, real‑world impact reflects her ongoing dedication to advancing the fields of epidemiology and biostatistics.
Copyright ©2026 Landmark Science, Inc. All Rights Reserved
